McCabe MS - Search Results

1

Incremental treatment costs in national cancer institute-sponsored clinical trials.

Goldman DP, Berry SH, McCabe MS, Kilgore ML, Potosky AL, Schoenbaum ML, Schonlau M, Weeks JC, Kaplan R, Escarce JJ. Goldman DP, et al. Among authors: mccabe ms. JAMA. 2003 Jun 11;289(22):2970-7. doi: 10.1001/jama.289.22.2970. JAMA. 2003. PMID: 12799405

2

Measuring the incremental cost of clinical cancer research.

Goldman DP, Schoenbaum ML, Potosky AL, Weeks JC, Berry SH, Escarce JJ, Weidmer BA, Kilgore ML, Wagle N, Adams JL, Figlin RA, Lewis JH, Cohen J, Kaplan R, McCabe M. Goldman DP, et al. J Clin Oncol. 2001 Jan 1;19(1):105-10. doi: 10.1200/JCO.2001.19.1.105. J Clin Oncol. 2001. PMID: 11134202

3

The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

Christian MC, McCabe MS, Korn EL, Abrams JS, Kaplan RS, Friedman MA. Christian MC, et al. Among authors: mccabe ms. N Engl J Med. 1995 Nov 30;333(22):1469-74. doi: 10.1056/NEJM199511303332206. N Engl J Med. 1995. PMID: 7477148 Free article.

4

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC. Sateren WB, et al. J Clin Oncol. 2002 Apr 15;20(8):2109-17. doi: 10.1200/JCO.2002.08.056. J Clin Oncol. 2002. PMID: 11956272

5

The Institute of Medicine report on high-quality cancer care: implications for oncology nursing.

Ferrell B, McCabe MS, Levit L. Ferrell B, et al. Among authors: mccabe ms. Oncol Nurs Forum. 2013 Nov;40(6):603-9. doi: 10.1188/13.ONF.603-609. Oncol Nurs Forum. 2013. PMID: 24161639

6

Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.

Koyfman SA, Agre P, Carlisle R, Classen L, Cheatham C, Finley JP, Kuhrik N, Kuhrik M, Mangskau TK, O'Neill J, Reddy CP, Kodish E, McCabe MS. Koyfman SA, et al. Among authors: mccabe ms. J Natl Cancer Inst. 2013 Jul 3;105(13):947-53. doi: 10.1093/jnci/djt143. J Natl Cancer Inst. 2013. PMID: 23821757

7

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, Budd T, Shoemaker D, Emanuel EJ, Grady C. Horstmann E, et al. Among authors: mccabe ms. N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220. N Engl J Med. 2005. PMID: 15745980 Free article.

8

Efforts to recruit the economically disadvantaged to national clinical trials.

McCabe MS, Varricchio CG, Padberg RM. McCabe MS, et al. Semin Oncol Nurs. 1994 May;10(2):123-9. doi: 10.1016/s0749-2081(05)80066-x. Semin Oncol Nurs. 1994. PMID: 8059110 Review.

9

Quality of Life in Clinical Cancer Trials. Introduction.

Varricchio CG, McCabe MS, Trimble E, Korn EL. Varricchio CG, et al. Among authors: mccabe ms. J Natl Cancer Inst Monogr. 1996;(20):vii-viii. J Natl Cancer Inst Monogr. 1996. PMID: 8750458 No abstract available.

10

Progress against cancer: the National Cancer Institute's role.

McCabe MS. McCabe MS. J Cancer Educ. 2003 Fall;18(3):161-3. doi: 10.1207/S15430154JCE1803_10. J Cancer Educ. 2003. PMID: 14512264 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page